<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">PONE-D-12-23843</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0058079</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Endocrinology</subject>
            <subj-group>
              <subject>Diabetic endocrinology</subject>
              <subj-group>
                <subject>Diabetes mellitus type 1</subject>
                <subject>Diabetes mellitus type 2</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Epidemiology</subject>
            <subj-group>
              <subject>Cancer epidemiology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Oncology</subject>
            <subj-group>
              <subject>Cancers and neoplasms</subject>
              <subj-group>
                <subject>Genitourinary tract tumors</subject>
                <subj-group>
                  <subject>Bladder cancer</subject>
                </subj-group>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Cancer prevention</subject>
              <subject>Cancer risk factors</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Urology</subject>
            <subj-group>
              <subject>Bladder and ureteric disorders</subject>
              <subject>Bladder cancer and urothelial neoplasias of the urinary tract</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Diabetes and Endocrinology</subject>
          <subject>Public Health and Epidemiology</subject>
          <subject>Urology</subject>
          <subject>Oncology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies</article-title>
        <alt-title alt-title-type="running-head">Diabetes Mellitus and Risk of Bladder Cancer</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Xu</surname>
            <given-names>Xin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wu</surname>
            <given-names>Jian</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Mao</surname>
            <given-names>Yeqing</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Zhu</surname>
            <given-names>Yi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Hu</surname>
            <given-names>Zhenghui</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Xu</surname>
            <given-names>Xianglai</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Lin</surname>
            <given-names>Yiwei</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Chen</surname>
            <given-names>Hong</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Zheng</surname>
            <given-names>Xiangyi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Qin</surname>
            <given-names>Jie</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Xie</surname>
            <given-names>Liping</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <addr-line>Department of Urology, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang Province, China</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Schooling</surname>
            <given-names>C. Mary</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>CUNY, United States of America</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">xielp@zjuem.zju.edu.cn</email></corresp>
        <fn fn-type="conflict">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: LX XX JW. Performed the experiments: XX YL HC. Analyzed the data: JW YM YZ ZH. Contributed reagents/materials/analysis tools: XZ JQ LX. Wrote the paper: XX LX.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>3</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <issue>3</issue>
      <elocation-id>e58079</elocation-id>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Xu et al</copyright-holder>
        <license xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Objective</title>
          <p>Diabetes is associated with increased risk of cancer at several sites, but its association with risk of bladder cancer is still controversial. We examined this association by conducting a systematic review and meta-analysis of cohort studies.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Studies were identified by searching PubMed, EMBASE, Scopus, Web of Science, Cochrane register, and Chinese National Knowledge Infrastructure (CNKI) databases through April 29, 2012. Summary relative risks (SRRs) with their corresponding 95% confidence intervals (CIs) were calculated using a random-effects model.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>A total of fifteen cohort studies were included in this meta-analysis. Analysis of all studies showed that diabetes was associated with a borderline statistically significant increased risk of bladder cancer (RR 1.11, 95% CI 1.00–1.23; p&lt;0.001 for heterogeneity; I<sup>2</sup> = 84%). When restricting the analysis to studies that had adjusted for cigarette smoking (n = 6) or more than three confounders (n = 7), the RRs were 1.32 (95% CI 1.18–1.49) and 1.20 (95% CI 1.02–1.42), respectively. There was no significant publication bias (p = 0.62 for Egger’s regression asymmetry test).</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Our findings support that diabetes was associated with an increased risk of bladder cancer. More future studies are warranted to get a better understanding of the association and to provide convincing evidence for clinical practice in bladder cancer prevention.</p>
        </sec>
      </abstract>
      <funding-group>
        <funding-statement>This study was supported by grants from National Key Clinical Specialty Construction Project of China, Key medical disciplines of Zhejiang province, Combination of traditional Chinese and Western medicine key disciplines of Zhejiang Province (2012-XK-A23), Health sector scientific research special project (201002010), National Natural Science Foundation of China (Grant No. 30900552) and Zhejiang Provincial Natural Science Foundation of China (Z2090356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="8"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Urinary bladder cancer ranks ninth in worldwide cancer incidence. It is the seventh most common malignancy in men and seventeenth in women <xref ref-type="bibr" rid="pone.0058079-Ploeg1">[1]</xref>. An estimated 386,300 new cases and 150,200 deaths from bladder cancer occurred in 2008 worldwide. The highest incidence rates are found in the countries of Europe, North America, and Northern Africa <xref ref-type="bibr" rid="pone.0058079-Jemal1">[2]</xref>. Increasing evidence suggests a significant influence of genetic predisposition on bladder incidence <xref ref-type="bibr" rid="pone.0058079-Burger1">[3]</xref>; the role of genetic factors in the etiology of bladder cancer is estimated to be about 31% <xref ref-type="bibr" rid="pone.0058079-Lichtenstein1">[4]</xref>. Cigarette smoking, occupational exposure to arylamines, and schistosomal infection are the most established external risk factors for bladder cancer <xref ref-type="bibr" rid="pone.0058079-MurtaNascimento1">[5]</xref>. However, other independent risk factors are not clearly known and their roles in bladder cancer severity, progression and outcomes need further exploration.</p>
      <p>Over the past few decades, the prevalence of diabetes mellitus has increased substantially and is highly suspected to be associated with an increased risk of some cancers. Considerable epidemiological studies and systematic reviews have shown positive associations between diabetes mellitus and the risk of biliary tract cancer <xref ref-type="bibr" rid="pone.0058079-Ren1">[6]</xref>, liver cancer <xref ref-type="bibr" rid="pone.0058079-Yang1">[7]</xref>, kidney cancer <xref ref-type="bibr" rid="pone.0058079-Larsson1">[8]</xref>, pancreas cancer <xref ref-type="bibr" rid="pone.0058079-Ben1">[9]</xref>, and colon and rectal cancer <xref ref-type="bibr" rid="pone.0058079-Yuhara1">[10]</xref>. Likewise, relationships between diabetes and bladder cancer incidence have also been evaluated, yielding controversial results. Most studies have reported positive, but nonsignificant associations, which might be explained by the insufficient statistical power of individual studies.</p>
      <p>A meta-analysis of the association between diabetes and bladder cancer risk published in 2006 concluded that diabetes was significantly associated with a higher risk (24%) of bladder cancer <xref ref-type="bibr" rid="pone.0058079-Larsson2">[11]</xref>. However, some limitations of this meta-analysis have to be mentioned, including a mixture of case–control and cohort studies, a mixture of bladder cancer incidence and mortality, lack of differentiation between type 1 and type 2 diabetes, and small numbers of bladder cancer case in most included studies. Since then, there are also many high-quality cohort studies on this association have been published <xref ref-type="bibr" rid="pone.0058079-Inoue1">[12]</xref>–<xref ref-type="bibr" rid="pone.0058079-Attner1">[21]</xref>, but controversy still reigns.</p>
      <p>Given the inconsistency of the existing literature and the insufficient statistical power of primary studies, we performed a meta-analysis of all eligible cohort studies to derive a more precise estimation of the relationship between diabetes and risk of bladder cancer. Furthermore, we also examined whether the association between them differs according to various study characteristics.</p>
    </sec>
    <sec id="s2" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec id="s2a">
        <title>Publication Search</title>
        <p>We carried out a search in PubMed, EMBASE, Scopus, Web of Science, Cochrane register, and Chinese National Knowledge Infrastructure (CNKI) databases, covering all the papers published from their inception to April 2012. The search strategy included terms for outcome (bladder neoplasm or bladder cancer or bladder tumor) and exposure (diabetes or diabetes mellitus). We evaluated potentially relevant publications by examining their titles and abstracts and all the studies matching the eligible criteria were retrieved. We also checked the references from retrieved articles and reviews to identify any additional relevant study.</p>
      </sec>
      <sec id="s2b">
        <title>Inclusion Criteria</title>
        <p>Studies included in this meta-analysis had to meet all the following criteria: (a) they had a cohort design or nested case-control design; (b) one of the exposure of interest was diabetes mellitus; (c) one of the outcome of interest was incidence of bladder cancer; and (d) studies provided rate ratio, hazard ratio or standardized incidence ratio (SIR) with their 95% CIs, or data to calculate them. Studies on mortality rates from bladder cancer were not included, as it could be confounded by survival related factors. We also did not consider studies in which the exposure of interest was mainly or solely type 1 diabetes, which was defined as early-onset (age &lt;30 years) of diabetes. If multiple publications from the same study population were available, the most recent and detailed study was eligible for inclusion in the meta-analysis.</p>
      </sec>
      <sec id="s2c">
        <title>Data Extraction</title>
        <p>Data were extracted independently by two authors using a predefined data collection form, with disagreements being resolved by consensus. For each study, the following characteristics were collected: first author’s name, year of publication, the country in which the study was carried out, participant characteristics (age and gender), year of study conducted, range for follow-up, sample size (cases and cohort size), methods of ascertainment of diabetes and bladder cancer, estimate effects with their 95% CIs, and covariates adjusted for in the analysis. From each study, we extracted the RR estimate that was adjusted for the greatest number of potential confounders.</p>
      </sec>
      <sec id="s2d">
        <title>Statistical Methods</title>
        <p>Studies that reported different measures of RR were included in this meta-analysis: rate ratio, hazard ratio and SIR. In practice, these three measures of effect yield similar estimates of RR because the absolute risk of bladder cancer is low.</p>
        <p>Summary RR estimates with their corresponding 95% CIs were calculated with the DerSimonian and Laird <xref ref-type="bibr" rid="pone.0058079-DerSimonian1">[22]</xref> random effects models, which consider both within-study and between-study variation. Subgroup analyses were carried out by (a) geographic region, (b) smoking status, (c) the number of covariates adjusted for, (d) methods of ascertainment of diabetes. Only the studies based on rate ratio or hazard ratio were included for subgroup analysis.</p>
        <p>Homogeneity of RRs across studies was tested by Q statistic (significance level at P&lt;0.10) and the I<sup>2</sup> score. Publication bias was assessed using Begg’s test (rank correlation method) <xref ref-type="bibr" rid="pone.0058079-Begg1">[23]</xref> and Egger’s test (linear regression method) <xref ref-type="bibr" rid="pone.0058079-Egger1">[24]</xref>. P&lt;0.05 was considered to be representative of a significant statistical publication bias. All of the statistical analyses were performed with STATA 11.0 (StataCorp, College Station, TX), using two-sided P-values.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Literature Search</title>
        <p><xref ref-type="fig" rid="pone-0058079-g001">Figure 1</xref> outlines our study selection process. Briefly, after removing duplications, the search strategy generated 468 articles. Of these, the majority were excluded after the first screening based on abstracts or titles, mainly because they were reviews, case-control studies, cross-sectional studies, or not relevant to our analysis.</p>
        <fig id="pone-0058079-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0058079.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Flowchart of study assessment and selection.</title>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0058079.g001" position="float" xlink:type="simple"/>
        </fig>
        <p>After full-text review of 21 papers, 6 studies were excluded for the reasons as follows: overlapping publications from the same study population <xref ref-type="bibr" rid="pone.0058079-Tseng1">[25]</xref>, <xref ref-type="bibr" rid="pone.0058079-Adami1">[26]</xref>; the outcome was cancer mortality <xref ref-type="bibr" rid="pone.0058079-Coughlin1">[27]</xref>, <xref ref-type="bibr" rid="pone.0058079-Tseng2">[28]</xref>; the exposure was solely type 1 diabetes <xref ref-type="bibr" rid="pone.0058079-Zendehdel1">[29]</xref>, <xref ref-type="bibr" rid="pone.0058079-Shu1">[30]</xref>. Thus, a total of 15 cohort studies, which met the inclusion criteria, were included in this meta-analysis.</p>
      </sec>
      <sec id="s3b">
        <title>Study Characteristics</title>
        <p>The characteristics of the 15 cohort studies are presented in <xref ref-type="table" rid="pone-0058079-t001">Tables 1</xref> and <xref ref-type="table" rid="pone-0058079-t002">2</xref>. Of these, 10 studies used rate ratio or hazard ratio as the measurement of RR <xref ref-type="bibr" rid="pone.0058079-Inoue1">[12]</xref>–<xref ref-type="bibr" rid="pone.0058079-Ogunleye1">[15]</xref>, <xref ref-type="bibr" rid="pone.0058079-Atchison1">[17]</xref>, <xref ref-type="bibr" rid="pone.0058079-Woolcott1">[18]</xref>, <xref ref-type="bibr" rid="pone.0058079-Lo1">[20]</xref>, <xref ref-type="bibr" rid="pone.0058079-Attner1">[21]</xref>, <xref ref-type="bibr" rid="pone.0058079-Jee1">[31]</xref>, <xref ref-type="bibr" rid="pone.0058079-Tripathi1">[32]</xref> (<xref ref-type="table" rid="pone-0058079-t001">Table 1</xref>), and 5 cohort studies used standardized incidence ratio as the measurement of RR <xref ref-type="bibr" rid="pone.0058079-Hemminki1">[16]</xref>, <xref ref-type="bibr" rid="pone.0058079-Wotton1">[19]</xref>, <xref ref-type="bibr" rid="pone.0058079-Wideroff1">[33]</xref>–<xref ref-type="bibr" rid="pone.0058079-Swerdlow1">[35]</xref> (<xref ref-type="table" rid="pone-0058079-t002">Table 2</xref>). The studies were conducted in the following regions: Europe (n = 7) <xref ref-type="bibr" rid="pone.0058079-Larsson3">[14]</xref>–<xref ref-type="bibr" rid="pone.0058079-Hemminki1">[16]</xref>, <xref ref-type="bibr" rid="pone.0058079-Wotton1">[19]</xref>, <xref ref-type="bibr" rid="pone.0058079-Attner1">[21]</xref>, <xref ref-type="bibr" rid="pone.0058079-Wideroff1">[33]</xref>, <xref ref-type="bibr" rid="pone.0058079-Swerdlow1">[35]</xref>, Asia (n = 4) <xref ref-type="bibr" rid="pone.0058079-Inoue1">[12]</xref>, <xref ref-type="bibr" rid="pone.0058079-Khan1">[13]</xref>, <xref ref-type="bibr" rid="pone.0058079-Lo1">[20]</xref>, <xref ref-type="bibr" rid="pone.0058079-Jee1">[31]</xref>, and USA (n = 4) <xref ref-type="bibr" rid="pone.0058079-Atchison1">[17]</xref>, <xref ref-type="bibr" rid="pone.0058079-Woolcott1">[18]</xref>, <xref ref-type="bibr" rid="pone.0058079-Tripathi1">[32]</xref>, <xref ref-type="bibr" rid="pone.0058079-Ragozzino1">[34]</xref>. The study population in ten studies consisted of both sexes <xref ref-type="bibr" rid="pone.0058079-Inoue1">[12]</xref>, <xref ref-type="bibr" rid="pone.0058079-Ogunleye1">[15]</xref>, <xref ref-type="bibr" rid="pone.0058079-Hemminki1">[16]</xref>, <xref ref-type="bibr" rid="pone.0058079-Woolcott1">[18]</xref>–<xref ref-type="bibr" rid="pone.0058079-Attner1">[21]</xref>, <xref ref-type="bibr" rid="pone.0058079-Wideroff1">[33]</xref>–<xref ref-type="bibr" rid="pone.0058079-Swerdlow1">[35]</xref>, four studies included men only <xref ref-type="bibr" rid="pone.0058079-Khan1">[13]</xref>, <xref ref-type="bibr" rid="pone.0058079-Larsson3">[14]</xref>, <xref ref-type="bibr" rid="pone.0058079-Atchison1">[17]</xref>, <xref ref-type="bibr" rid="pone.0058079-Jee1">[31]</xref> and one study included women only <xref ref-type="bibr" rid="pone.0058079-Tripathi1">[32]</xref>. All included studies were published between 1982 and 2012, of which 66.7% (n = 10) <xref ref-type="bibr" rid="pone.0058079-Inoue1">[12]</xref>–<xref ref-type="bibr" rid="pone.0058079-Attner1">[21]</xref> were published in 2006 or more recent years, and were not included in previous meta-analysis. The cohort ranged in size from 1,135 <xref ref-type="bibr" rid="pone.0058079-Ragozzino1">[34]</xref> to 4,501,578 <xref ref-type="bibr" rid="pone.0058079-Atchison1">[17]</xref>. Diabetes status was ascertained by self-reported history of diabetes mellitus, medical records or blood glucose level. Diagnosis of bladder cancer was based on medical record or cancer registry data, except one using histological verification <xref ref-type="bibr" rid="pone.0058079-Ragozzino1">[34]</xref>. Adjustments were made for potential confounders of one or more factors in all studies.</p>
        <table-wrap id="pone-0058079-t001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0058079.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Characteristics of cohort studies of diabetes and bladder cancer based on rate ratio and hazard ratio.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0058079-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0058079.t001" xlink:type="simple"/>
            <table>
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Study</td>
                  <td align="left" rowspan="1" colspan="1">Year of study conducted</td>
                  <td align="left" rowspan="1" colspan="1">Follow up, years</td>
                  <td align="left" rowspan="1" colspan="1">Age/gender</td>
                  <td align="left" rowspan="1" colspan="1">Cases/Cohort</td>
                  <td align="left" rowspan="1" colspan="1">Diabetes assessment</td>
                  <td align="left" rowspan="1" colspan="1">Bladder cancer ascertainment</td>
                  <td align="left" rowspan="1" colspan="1">Adjustments</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Lo et al./2012</td>
                  <td align="left" rowspan="1" colspan="1">1996–2009</td>
                  <td align="left" rowspan="1" colspan="1">3.5</td>
                  <td align="left" rowspan="1" colspan="1">All ages</td>
                  <td align="left" rowspan="1" colspan="1">4,311/1,790,868</td>
                  <td align="left" rowspan="1" colspan="1">Medical records</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Sex, age, urbanization, hypertension and hyperlipidemia.</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(Taiwan)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 49.1%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Attner et al./2012</td>
                  <td align="left" rowspan="1" colspan="1">1998–2007</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">45–84 (86%)</td>
                  <td align="left" rowspan="1" colspan="1">19,756/167,080</td>
                  <td align="left" rowspan="1" colspan="1">Medical records</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Age and gender</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(Sweden)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 53%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 1 and 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Atchison et al./2011</td>
                  <td align="left" rowspan="1" colspan="1">1969–1996</td>
                  <td align="left" rowspan="1" colspan="1">10.5</td>
                  <td align="left" rowspan="1" colspan="1">18–100</td>
                  <td align="left" rowspan="1" colspan="1">19,300/4,501,578</td>
                  <td align="left" rowspan="1" colspan="1">Medical records</td>
                  <td align="left" rowspan="1" colspan="1">Medical records</td>
                  <td align="left" rowspan="1" colspan="1">Age, time, latency, race, number of hospital visits, alcohol-related</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(USA)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 100%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">conditions, obesity and chronic obstructive pulmonary disease</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Woolcott et al./2011</td>
                  <td align="left" rowspan="1" colspan="1">1993–2004</td>
                  <td align="left" rowspan="1" colspan="1">10.7</td>
                  <td align="left" rowspan="1" colspan="1">45–75</td>
                  <td align="left" rowspan="1" colspan="1">818/185,816</td>
                  <td align="left" rowspan="1" colspan="1">Self-reported</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Ethnicity, sex, smoking status, intensity and duration, and employment in a</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(USA)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 45%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 1 and 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">high risk Industry</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ogunleye et al./2009</td>
                  <td align="left" rowspan="1" colspan="1">1993–2004</td>
                  <td align="left" rowspan="1" colspan="1">3.9</td>
                  <td align="left" rowspan="1" colspan="1">All ages</td>
                  <td align="left" rowspan="1" colspan="1">68/9,577</td>
                  <td align="left" rowspan="1" colspan="1">Medical records</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Age, sex and deprivation</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(Scotland, UK)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 53%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Larsson et al./2008</td>
                  <td align="left" rowspan="1" colspan="1">1997–2007</td>
                  <td align="left" rowspan="1" colspan="1">9.3</td>
                  <td align="left" rowspan="1" colspan="1">45–79</td>
                  <td align="left" rowspan="1" colspan="1">414/45,906</td>
                  <td align="left" rowspan="1" colspan="1">Self-reported</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Age, education, smoking status and pack-years of smoking</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(Sweden)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 100%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 1 and 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Inoue et al./2006</td>
                  <td align="left" rowspan="1" colspan="1">1988–1999</td>
                  <td align="left" rowspan="1" colspan="1">14</td>
                  <td align="left" rowspan="1" colspan="1">40–69</td>
                  <td align="left" rowspan="1" colspan="1">135/97,771</td>
                  <td align="left" rowspan="1" colspan="1">Self-reported</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Age, study area, history of cerebrovascular disease, history of ischemic</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(Japan)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 47.6%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 1 and 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">heart disease, smoking, physical activity, BMI, alcohol intake, green</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">vegetable intake, coffee</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Khan et al./2006</td>
                  <td align="left" rowspan="1" colspan="1">1988–1997</td>
                  <td align="left" rowspan="1" colspan="1">18–20</td>
                  <td align="left" rowspan="1" colspan="1">40–79</td>
                  <td align="left" rowspan="1" colspan="1">60/56,881</td>
                  <td align="left" rowspan="1" colspan="1">Self-reported</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Age, smoking, BMI and alcohol</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(Japan)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 41%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 1 and 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Jee et al./2005</td>
                  <td align="left" rowspan="1" colspan="1">1992–2002</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">30–95</td>
                  <td align="left" rowspan="1" colspan="1">NA/829,770</td>
                  <td align="left" rowspan="1" colspan="1">Blood glucose level or</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry and</td>
                  <td align="left" rowspan="1" colspan="1">Age, smoking and alcohol</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(Korea)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 64%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">medication use (type 2)</td>
                  <td align="left" rowspan="1" colspan="1">medical records</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Tripathi et al./2002</td>
                  <td align="left" rowspan="1" colspan="1">1986–1998</td>
                  <td align="left" rowspan="1" colspan="1">13</td>
                  <td align="left" rowspan="1" colspan="1">55–69</td>
                  <td align="left" rowspan="1" colspan="1">112/37,459</td>
                  <td align="left" rowspan="1" colspan="1">Self-reported</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Age, smoking, regular physical activity, BMI, alcohol, married, occupation</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(USA)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 0%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 1 and 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">lifetime</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>NA, data not applicable; BMI, body mass index.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="pone-0058079-t002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0058079.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Characteristics of cohort studies of diabetes and bladder cancer based on standardized incidence ratio.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0058079-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0058079.t002" xlink:type="simple"/>
            <table>
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Study</td>
                  <td align="left" rowspan="1" colspan="1">Year of studyconducted</td>
                  <td align="left" rowspan="1" colspan="1">Follow up,years</td>
                  <td align="left" rowspan="1" colspan="1">Age/gender</td>
                  <td align="left" rowspan="1" colspan="1">Cases/Cohort</td>
                  <td align="left" rowspan="1" colspan="1">Diabetes assessment</td>
                  <td align="left" rowspan="1" colspan="1">Bladder cancerascertainment</td>
                  <td align="left" rowspan="1" colspan="1">Adjustments</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Wotton et al./2011</td>
                  <td align="left" rowspan="1" colspan="1">1963–2008</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">≥30</td>
                  <td align="left" rowspan="1" colspan="1">2,385/484,356</td>
                  <td align="left" rowspan="1" colspan="1">Medical records</td>
                  <td align="left" rowspan="1" colspan="1">Medical records</td>
                  <td align="left" rowspan="1" colspan="1">Sex, age in 5-year bands, time period in single calendar years</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(UK)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male:54%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(estimated 90% type 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">and district of residence</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Hemminki et al./2010</td>
                  <td align="left" rowspan="1" colspan="1">1964–2007</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">&gt;39</td>
                  <td align="left" rowspan="1" colspan="1">483/125,126</td>
                  <td align="left" rowspan="1" colspan="1">Medical records</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Age, sex, period, region and socioeconomic status</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(Sweden)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: NA</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Swerdlow et al./2005</td>
                  <td align="left" rowspan="1" colspan="1">1972–2003</td>
                  <td align="left" rowspan="1" colspan="1">18</td>
                  <td align="left" rowspan="1" colspan="1">30–49</td>
                  <td align="left" rowspan="1" colspan="1">20/5,066</td>
                  <td align="left" rowspan="1" colspan="1">Self-reported</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Age, sex, country of residence and calendar year</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(UK)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male:58.1%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(estimated 36% type 1, 64% type 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Wideroff et al./1997</td>
                  <td align="left" rowspan="1" colspan="1">1977–1989</td>
                  <td align="left" rowspan="1" colspan="1">17</td>
                  <td align="left" rowspan="1" colspan="1">64(m); 69(f)</td>
                  <td align="left" rowspan="1" colspan="1">493/109,581</td>
                  <td align="left" rowspan="1" colspan="1">Medical records</td>
                  <td align="left" rowspan="1" colspan="1">Cancer registry</td>
                  <td align="left" rowspan="1" colspan="1">Age, sex and calendar year</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(Denmark)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 49%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(type 1 and 2)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ragozzino et al./1982</td>
                  <td align="left" rowspan="1" colspan="1">1945–1969</td>
                  <td align="left" rowspan="1" colspan="1">8.6</td>
                  <td align="left" rowspan="1" colspan="1">61</td>
                  <td align="left" rowspan="1" colspan="1">7/1,135</td>
                  <td align="left" rowspan="1" colspan="1">Blood glucose level</td>
                  <td align="left" rowspan="1" colspan="1">Histological verification</td>
                  <td align="left" rowspan="1" colspan="1">Age</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">(USA)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Male: 53%</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">(NA)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt102">
              <label/>
              <p>NA, data not applicable; m, male; f, female.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s3c">
        <title>Diabetes Mellitus and Risk of Bladder Cancer</title>
        <p>The overall RR with its 95% CI showed a borderline statistically significant association between diabetes mellitus and risk of bladder cancer (<xref ref-type="fig" rid="pone-0058079-g002">Fig. 2</xref>, RR 1.11, 95% CI 1.00–1.23). The summary RRs with 95% CIs were 1.01 (95% CI 0.82–1.24) for studies using standardized incidence ratio, and 1.19 (95% CI 1.04–1.36) for rate ratio or hazard ratio. There was statistically significant heterogeneity among studies (p&lt;0.001 for heterogeneity; I<sup>2</sup> = 84.0%).</p>
        <fig id="pone-0058079-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0058079.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Relative risks for the association between diabetes and risk of bladder cancer in cohort studies.</title>
            <p>Studies are sub-grouped according to the measurements of relative risk. Diamonds represent study-specific relative risks or summary relative risks with 95% CIs; horizontal lines represent 95% confidence intervals (CIs). Test for heterogeneity among studies: p&lt;0.001, I<sup>2</sup> = 84.0%. 1, cohort studies (n = 10) use incidence rate as the measurement of relative risk. 2, cohort studies (n = 5) use standardized incidence rate as the measurement of relative risk.</p>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0058079.g002" position="float" xlink:type="simple"/>
        </fig>
        <p>Next, we conducted subgroup meta-analysis by various study characteristics (<xref ref-type="table" rid="pone-0058079-t003">Table 3</xref>). In the subgroup analysis by geographical area, the association between diabetes and bladder cancer was more significant for studies conducted in Asia (RR 1.21, 95% CI 1.15–1.28; p = 0.658 for heterogeneity; I<sup>2</sup> = 0%) than in Europe (RR 1.09, 95% CI 0.85–1.40; p = 0.189 for heterogeneity; I<sup>2</sup> = 39.9%) or USA (RR 1.28, 95% CI 0.90–1.81; p&lt;0.001 for heterogeneity; I<sup>2</sup> = 88.6%). In further stratified analysis by the methods of ascertainment of diabetes, the summary RRs with 95% CIs were 1.34 (95% CI 1.11–1.62) for studies using self-report, and 1.11 (95% CI 0.95–1.31) for others methods.</p>
        <table-wrap id="pone-0058079-t003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0058079.t003</object-id>
          <label>Table 3</label>
          <caption>
            <title>Subgroup analysis of relative risks for the association between diabetes and bladder cancer.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0058079-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0058079.t003" xlink:type="simple"/>
            <table>
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Subgroup</td>
                  <td align="left" rowspan="1" colspan="1">References</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td colspan="3" align="left" rowspan="1">Heterogeneity test</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">RR (95% CI)</td>
                  <td align="left" rowspan="1" colspan="1">Q</td>
                  <td align="left" rowspan="1" colspan="1">P</td>
                  <td align="left" rowspan="1" colspan="1">I<sup>2</sup> (%)</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td colspan="6" align="left" rowspan="1">
                    <bold>The measure of relative risk</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Standardized incidence ratio</td>
                  <td align="left" rowspan="1" colspan="1">16, 19, 33–35</td>
                  <td align="left" rowspan="1" colspan="1">1.01 (0.82, 1.24)</td>
                  <td align="left" rowspan="1" colspan="1">47.44</td>
                  <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                  <td align="left" rowspan="1" colspan="1">87.4</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Rate ratio or hazard ratio</td>
                  <td align="left" rowspan="1" colspan="1">12–15, 17, 18, 20, 21, 31, 32</td>
                  <td align="left" rowspan="1" colspan="1">1.19 (1.04, 1.36)</td>
                  <td align="left" rowspan="1" colspan="1">57.74</td>
                  <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                  <td align="left" rowspan="1" colspan="1">82.7</td>
                </tr>
                <tr>
                  <td colspan="6" align="left" rowspan="1">
                    <bold>Geographical region</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Europe</td>
                  <td align="left" rowspan="1" colspan="1">14, 15, 21</td>
                  <td align="left" rowspan="1" colspan="1">1.09 (0.85, 1.40)</td>
                  <td align="left" rowspan="1" colspan="1">3.33</td>
                  <td align="left" rowspan="1" colspan="1">0.189</td>
                  <td align="left" rowspan="1" colspan="1">39.9</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">USA</td>
                  <td align="left" rowspan="1" colspan="1">17, 18, 32</td>
                  <td align="left" rowspan="1" colspan="1">1.28 (0.90, 1.81)</td>
                  <td align="left" rowspan="1" colspan="1">17.47</td>
                  <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                  <td align="left" rowspan="1" colspan="1">88.6</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Asia</td>
                  <td align="left" rowspan="1" colspan="1">12, 13, 20, 31</td>
                  <td align="left" rowspan="1" colspan="1">1.21 (1.15, 1.28)</td>
                  <td align="left" rowspan="1" colspan="1">2.43</td>
                  <td align="left" rowspan="1" colspan="1">0.658</td>
                  <td align="left" rowspan="1" colspan="1">0.0</td>
                </tr>
                <tr>
                  <td colspan="6" align="left" rowspan="1">
                    <bold>Adjustment for more than three confounders</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">12–14, 17, 18, 20, 32</td>
                  <td align="left" rowspan="1" colspan="1">1.20 (1.02, 1.42)</td>
                  <td align="left" rowspan="1" colspan="1">48.45</td>
                  <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                  <td align="left" rowspan="1" colspan="1">85.6</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">No</td>
                  <td align="left" rowspan="1" colspan="1">15, 21, 31</td>
                  <td align="left" rowspan="1" colspan="1">1.17 (0.94, 1.47)</td>
                  <td align="left" rowspan="1" colspan="1">4.62</td>
                  <td align="left" rowspan="1" colspan="1">0.099</td>
                  <td align="left" rowspan="1" colspan="1">56.7</td>
                </tr>
                <tr>
                  <td colspan="6" align="left" rowspan="1">
                    <bold>Adjustment for smoking</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">12–14, 18, 31, 32</td>
                  <td align="left" rowspan="1" colspan="1">1.32 (1.18, 1.49)</td>
                  <td align="left" rowspan="1" colspan="1">5.62</td>
                  <td align="left" rowspan="1" colspan="1">0.467</td>
                  <td align="left" rowspan="1" colspan="1">0.0</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">No</td>
                  <td align="left" rowspan="1" colspan="1">15, 17, 20, 21</td>
                  <td align="left" rowspan="1" colspan="1">1.07 (0.90, 1.27)</td>
                  <td align="left" rowspan="1" colspan="1">38.22</td>
                  <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                  <td align="left" rowspan="1" colspan="1">92.2</td>
                </tr>
                <tr>
                  <td colspan="6" align="left" rowspan="1">
                    <bold>Diabetes ascertainment</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Self-report</td>
                  <td align="left" rowspan="1" colspan="1">12–14, 18, 32</td>
                  <td align="left" rowspan="1" colspan="1">1.34 (1.11, 1.62)</td>
                  <td align="left" rowspan="1" colspan="1">5.62</td>
                  <td align="left" rowspan="1" colspan="1">0.345</td>
                  <td align="left" rowspan="1" colspan="1">11.0</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Others methods</td>
                  <td align="left" rowspan="1" colspan="1">15, 17, 20, 21, 31</td>
                  <td align="left" rowspan="1" colspan="1">1.11 (0.95, 1.31)</td>
                  <td align="left" rowspan="1" colspan="1">44.32</td>
                  <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                  <td align="left" rowspan="1" colspan="1">91.0</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt103">
              <label/>
              <p>RR, relative risk; CI, confidence interval.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>We also investigated the impact of confounding factors on the estimates of relative risk (<xref ref-type="table" rid="pone-0058079-t003">Table 3</xref>). Cigarette smoking is a risk factor for both diabetes and bladder cancer, and thus a potential confounder of the relationship between diabetes and risk of bladder cancer. Among the six studies that controlled for cigarette smoking, the pooled RR was 1.32 (95% CI 1.18–1.49; p = 0.467 for heterogeneity; I<sup>2</sup> = 0%). Moreover, some studies in our analysis adjusted for more than three confounders. Therefore, we examined if more thoroughly adjusting for potential confounders affected the pooled RR and degree of heterogeneity (<xref ref-type="table" rid="pone-0058079-t003">Table 3</xref>). The effect estimate for studies that adjusted for more than three confounders was RR, 1.20 (95% CI 1.02–1.42; p&lt;0.001 for heterogeneity; I<sup>2</sup> = 85.6%).</p>
      </sec>
      <sec id="s3d">
        <title>Publication Bias</title>
        <p>There was no evidence of significant publication bias either with the Begg’s test (P = 0.76) or with Egger’s test (<xref ref-type="fig" rid="pone-0058079-g003">Fig. 3</xref>, P = 0.62).</p>
        <fig id="pone-0058079-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0058079.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Funnel plot of cohort studies evaluating the association between diabetes and bladder cancer.</title>
            <p>Egger’s regression asymmetry test (p = 0.62). Standardized effect was defined as the odds ratio divided by its standard error. Precision was defined as the inverse of the standard error.</p>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0058079.g003" position="float" xlink:type="simple"/>
        </fig>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>The findings of this meta-analysis of fifteen cohort studies indicate that diabetes is associated with an 11% increased risk of bladder cancer. It tended to be more remarkable for studies with a rate ratio or hazard ratio as the measure of relative risk than for studies with a standardized incidence ratio.</p>
      <p>At present, whether diabetes is independently associated with incidence of bladder cancer remains controversial. Results from our subgroup analysis restricted to studies with control for smoking or adjusted for more than three confounders were more robust than that reported in the overall analysis, which indicated that the association may have been diluted by poor study methodologies and diabetes is probably an independent risk factor of bladder cancer.</p>
      <p>Of note, the association between diabetes and bladder cancer was more pronounced in studies with a rate ratio or hazard ratio as the measure of relative risk than in studies with a standardized incidence ratio. Studies using standardized incidence ratio and standardized mortality ratio to estimate the relative risk may underestimate the true relative risk <xref ref-type="bibr" rid="pone.0058079-Chaturvedi1">[36]</xref>, <xref ref-type="bibr" rid="pone.0058079-Jones1">[37]</xref>. Because if the general population is taken to represent unexposed persons, it is almost inevitably biased in that it comprises all types of people including exposed ones <xref ref-type="bibr" rid="pone.0058079-Jones1">[37]</xref>. Therefore, the summary RRs risk of this meta-analysis may have been attenuated by the results from studies using standardized incidence ratio as the measure of relative risk and the results of our meta-analysis were actually statistically robust.</p>
      <p>The association between the duration of diabetes and risk of bladder cancer have been assessed in some studies, and inconsistent results were found <xref ref-type="bibr" rid="pone.0058079-Inoue1">[12]</xref>, <xref ref-type="bibr" rid="pone.0058079-Khan1">[13]</xref>, <xref ref-type="bibr" rid="pone.0058079-Ogunleye1">[15]</xref>–<xref ref-type="bibr" rid="pone.0058079-Atchison1">[17]</xref>, <xref ref-type="bibr" rid="pone.0058079-Lo1">[20]</xref>, <xref ref-type="bibr" rid="pone.0058079-Ragozzino1">[34]</xref>. In the study by Hemminki et al. <xref ref-type="bibr" rid="pone.0058079-Hemminki1">[16]</xref>, the standardized incidence ratio of bladder cancer declined from 1.37 with no latency period to 0.96 for a 5 year latency period, while Ogunleye et al. <xref ref-type="bibr" rid="pone.0058079-Ogunleye1">[15]</xref> reported that the RR between diabetes and bladder cancer was 0.70 (95% CI 0.40–1.21) when including all cases and 0.53 (95% CI 0.24–1.15) when excluding cases diagnosed within the first year of follow-up. The study conducted by Atchison et al. <xref ref-type="bibr" rid="pone.0058079-Atchison1">[17]</xref> also suggested the risk of bladder cancer declined over time. However, another three reports <xref ref-type="bibr" rid="pone.0058079-Inoue1">[12]</xref>, <xref ref-type="bibr" rid="pone.0058079-Khan1">[13]</xref>, <xref ref-type="bibr" rid="pone.0058079-Lo1">[20]</xref> found higher relative risks after excluding the first 2, 3.5 or 5 years of follow-up. Because of the inconsistent results, it remains unclear whether the duration of diabetes is directly associated with the risk of bladder cancer. Interestingly, we noticed that the studies reported risk reduction over time were conducted in western countries, while higher relative risks for longer duration were suggested by studies from Asian countries. The mechanism behind this difference is not clear and should be further studied in the future.</p>
      <p>A relationship between diabetes and risk of bladder cancer is biologically plausible. Type 2 diabetes is associated with insulin resistance, compensatory hyper-insulinemia, and up-regulated level of IGF-1. IGF-1 could stimulate cell proliferation and inhibit apoptosis. Several epidemiological studies have implicated IGF-I in the development of breast and colorectal cancers <xref ref-type="bibr" rid="pone.0058079-Key1">[38]</xref>, <xref ref-type="bibr" rid="pone.0058079-Rinaldi1">[39]</xref>. A USA case-control study also has found statistically significantly higher circulating levels of IGF-I in bladder cancer cases than in controls <xref ref-type="bibr" rid="pone.0058079-Zhao1">[40]</xref>. An important role of IGF-I in the development of bladder cancer is also supported by studies in animals <xref ref-type="bibr" rid="pone.0058079-Dunn1">[41]</xref>. Additionally, diabetes is also associated with an increased risk of urinary tract infection <xref ref-type="bibr" rid="pone.0058079-Funfstuck1">[42]</xref> and urinary tract calculi <xref ref-type="bibr" rid="pone.0058079-Chen1">[43]</xref>, which have been related to various histologic types of bladder cancer, including transitional cell carcinoma, the predominant type <xref ref-type="bibr" rid="pone.0058079-Jankovic1">[44]</xref>, <xref ref-type="bibr" rid="pone.0058079-Chow1">[45]</xref>.</p>
      <p>Substantial heterogeneity was observed among studies of diabetes and bladder cancer risk, which may be due to different adjustment for confounding factors and different mixtures of type 1 and type 2 diabetic patients. Some studies included in this meta-analysis did not distinguish between type 1 and type 2 diabetes. As type-1 diabetes may not be related to bladder cancer risk <xref ref-type="bibr" rid="pone.0058079-Zendehdel1">[29]</xref>, <xref ref-type="bibr" rid="pone.0058079-Shu1">[30]</xref>, different proportions of type 1 and type 2 diabetic participants in the studies may in part account for the observed heterogeneity.</p>
      <p>A major strength of our study is that with the accumulating evidence and enlarged sample size, we have enhanced statistical power to derive a more precise and reliable estimation of the relationship between diabetes and bladder cancer risk. Nonetheless, some limitations should be mentioned. One potential limitation of this meta-analysis was the various assessments of diabetes used between studies. Some studies used self-report as the method of diabetes ascertainment, which may lead to some misclassification of diabetic persons as non-diabetic persons. This underreporting may result in an underestimate of the magnitude of the association between diabetes and bladder cancer risk. However, earlier studies have suggested that self-reported diabetes have good agreement with medical records <xref ref-type="bibr" rid="pone.0058079-Okura1">[46]</xref>, <xref ref-type="bibr" rid="pone.0058079-Margolis1">[47]</xref>. A second limitation is the uncontrolled or unmeasured risk factors potentially produce biases. Although the magnitude of increased risk reported in studies adjusted for more than three confounders was more robust than that reported in the overall analysis, we still cannot rule out the possibility that residual confounding could affect the results. Recently, some studies reported that thiazolidinediones, particularly pioglitazone, were associated with an increased risk of bladder cancer <xref ref-type="bibr" rid="pone.0058079-Neumann1">[48]</xref>, <xref ref-type="bibr" rid="pone.0058079-Azoulay1">[49]</xref>. However, most of the studies included in this meta-analysis did not provide the information of oral hypoglycemic use. Thus we failed to evaluate the therapeutic agents’ influence on the association between the diabetes and bladder cancer risk. Finally, in any meta-analysis, the possibility of publication bias is of concern, because small studies with null results tend not to be published. However, we found no evidence of publication bias in this meta-analysis.</p>
      <p>In summary, our findings support that diabetes was associated with the increased risk of bladder cancer. More future studies are warranted to get a better understanding of the association and to provide convincing evidence for clinical practice in bladder cancer prevention.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pone.0058079-Ploeg1">
        <label>1</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ploeg</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aben</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Kiemeney</surname><given-names>LA</given-names></name> (<year>2009</year>) <article-title>The present and future burden of urinary bladder cancer in the world</article-title>. <source>World J Urol</source> <volume>27</volume>: <fpage>289</fpage>–<lpage>293</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Jemal1">
        <label>2</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bray</surname><given-names>F</given-names></name> (<year>2011</year>) <collab xlink:type="simple">Center MM, Ferlay J, Ward E, et al</collab> (<year>2011</year>) <article-title>Global cancer statistics</article-title>. <source>CA Cancer J Clin</source> <volume>61</volume>: <fpage>69</fpage>–<lpage>90</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Burger1">
        <label>3</label>
        <mixed-citation publication-type="other" xlink:type="simple">Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, <etal>et al</etal>.. (2012) Epidemiology and Risk Factors of Urothelial Bladder Cancer. Eur Urol.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Lichtenstein1">
        <label>4</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lichtenstein</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Holm</surname><given-names>NV</given-names></name>, <name name-style="western"><surname>Verkasalo</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Iliadou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kaprio</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland</article-title>. <source>N Engl J Med</source> <volume>343</volume>: <fpage>78</fpage>–<lpage>85</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-MurtaNascimento1">
        <label>5</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Murta-Nascimento</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schmitz-Drager</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Zeegers</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Steineck</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kogevinas</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Epidemiology of urinary bladder cancer: from tumor development to patient’s death</article-title>. <source>World J Urol</source> <volume>25</volume>: <fpage>285</fpage>–<lpage>295</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Ren1">
        <label>6</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ren</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>YQ</given-names></name> (<year>2011</year>) <article-title>Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis</article-title>. <source>Cancer Causes Control</source> <volume>22</volume>: <fpage>837</fpage>–<lpage>847</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Yang1">
        <label>7</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Va</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bray</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies</article-title>. <source>PLoS One</source> <volume>6</volume>: <fpage>e27326</fpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Larsson1">
        <label>8</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larsson</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Wolk</surname><given-names>A</given-names></name> (<year>2011</year>) <article-title>Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies</article-title>. <source>Diabetologia</source> <volume>54</volume>: <fpage>1013</fpage>–<lpage>1018</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Ben1">
        <label>9</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ben</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ning</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies</article-title>. <source>Eur J Cancer</source> <volume>47</volume>: <fpage>1928</fpage>–<lpage>1937</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Yuhara1">
        <label>10</label>
        <mixed-citation publication-type="other" xlink:type="simple">Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, <etal>et al</etal>.. (2011) Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 106: 1911–1921; quiz 1922.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Larsson2">
        <label>11</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larsson</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Orsini</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Brismar</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wolk</surname><given-names>A</given-names></name> (<year>2006</year>) <article-title>Diabetes mellitus and risk of bladder cancer: a meta-analysis</article-title>. <source>Diabetologia</source> <volume>49</volume>: <fpage>2819</fpage>–<lpage>2823</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Inoue1">
        <label>12</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Inoue</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Iwasaki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Otani</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sasazuki</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Noda</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan</article-title>. <source>Arch Intern Med</source> <volume>166</volume>: <fpage>1871</fpage>–<lpage>1877</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Khan1">
        <label>13</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mori</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fujino</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shibata</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sakauchi</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study</article-title>. <source>Asian Pac J Cancer Prev</source> <volume>7</volume>: <fpage>253</fpage>–<lpage>259</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Larsson3">
        <label>14</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larsson</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Andersson</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Johansson</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Wolk</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men</article-title>. <source>Eur J Cancer</source> <volume>44</volume>: <fpage>2655</fpage>–<lpage>2660</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Ogunleye1">
        <label>15</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ogunleye</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Ogston</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>JM</given-names></name> (<year>2009</year>) <article-title>A cohort study of the risk of cancer associated with type 2 diabetes</article-title>. <source>Br J Cancer</source> <volume>101</volume>: <fpage>1199</fpage>–<lpage>1201</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Hemminki1">
        <label>16</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hemminki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Sundquist</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sundquist</surname><given-names>K</given-names></name> (<year>2010</year>) <article-title>Risk of cancer following hospitalization for type 2 diabetes</article-title>. <source>Oncologist</source> <volume>15</volume>: <fpage>548</fpage>–<lpage>555</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Atchison1">
        <label>17</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Atchison</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Gridley</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Carreon</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Leitzmann</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>McGlynn</surname><given-names>KA</given-names></name> (<year>2011</year>) <article-title>Risk of cancer in a large cohort of U.S. veterans with diabetes</article-title>. <source>Int J Cancer</source> <volume>128</volume>: <fpage>635</fpage>–<lpage>643</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Woolcott1">
        <label>18</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woolcott</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Maskarinec</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Haiman</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Henderson</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Kolonel</surname><given-names>LN</given-names></name> (<year>2011</year>) <article-title>Diabetes and urothelial cancer risk: the Multiethnic Cohort study</article-title>. <source>Cancer Epidemiol</source> <volume>35</volume>: <fpage>551</fpage>–<lpage>554</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Wotton1">
        <label>19</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wotton</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Yeates</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Goldacre</surname><given-names>MJ</given-names></name> (<year>2011</year>) <article-title>Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies</article-title>. <source>Diabetologia</source> <volume>54</volume>: <fpage>527</fpage>–<lpage>534</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Lo1">
        <label>20</label>
        <mixed-citation publication-type="other" xlink:type="simple">Lo SF, Chang SN, Muo CH, Chen SY, Liao FY, <etal>et al</etal>.. (2012) Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Attner1">
        <label>21</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Attner</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Landin-Olsson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lithman</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Noreen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Olsson</surname><given-names>H</given-names></name> (<year>2012</year>) <article-title>Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden</article-title>. <source>Cancer Causes Control</source> <volume>23</volume>: <fpage>769</fpage>–<lpage>777</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-DerSimonian1">
        <label>22</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Begg1">
        <label>23</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Egger1">
        <label>24</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Tseng1">
        <label>25</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tseng</surname><given-names>CH</given-names></name> (<year>2011</year>) <article-title>Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan</article-title>. <source>Diabetologia</source> <volume>54</volume>: <fpage>2009</fpage>–<lpage>2015</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Adami1">
        <label>26</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adami</surname><given-names>HO</given-names></name>, <name name-style="western"><surname>McLaughlin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ekbom</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Berne</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Silverman</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>1991</year>) <article-title>Cancer risk in patients with diabetes mellitus</article-title>. <source>Cancer Causes Control</source> <volume>2</volume>: <fpage>307</fpage>–<lpage>314</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Coughlin1">
        <label>27</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coughlin</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Calle</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Teras</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Petrelli</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thun</surname><given-names>MJ</given-names></name> (<year>2004</year>) <article-title>Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults</article-title>. <source>Am J Epidemiol</source> <volume>159</volume>: <fpage>1160</fpage>–<lpage>1167</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Tseng2">
        <label>28</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tseng</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Chong</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Tseng</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>TT</given-names></name> (<year>2009</year>) <article-title>Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan</article-title>. <source>Ann Med</source> <volume>41</volume>: <fpage>371</fpage>–<lpage>379</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Zendehdel1">
        <label>29</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zendehdel</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nyren</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Ostenson</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Adami</surname><given-names>HO</given-names></name>, <name name-style="western"><surname>Ekbom</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden</article-title>. <source>J Natl Cancer Inst</source> <volume>95</volume>: <fpage>1797</fpage>–<lpage>1800</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Shu1">
        <label>30</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Sundquist</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sundquist</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden</article-title>. <source>Diabet Med</source> <volume>27</volume>: <fpage>791</fpage>–<lpage>797</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Jee1">
        <label>31</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jee</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Ohrr</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sull</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Yun</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Fasting serum glucose level and cancer risk in Korean men and women</article-title>. <source>JAMA</source> <volume>293</volume>: <fpage>194</fpage>–<lpage>202</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Tripathi1">
        <label>32</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tripathi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Folsom</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>KE</given-names></name> (<year>2002</year>) <article-title>Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women’s Health Study</article-title>. <source>Cancer</source> <volume>95</volume>: <fpage>2316</fpage>–<lpage>2323</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Wideroff1">
        <label>33</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wideroff</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gridley</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mellemkjaer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Linet</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark</article-title>. <source>J Natl Cancer Inst</source> <volume>89</volume>: <fpage>1360</fpage>–<lpage>1365</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Ragozzino1">
        <label>34</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">Ragozzino M, Melton LJ, 3rd, Chu CP, Palumbo PJ</collab> (<year>1982</year>) <article-title>Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus</article-title>. <source>J Chronic Dis</source> <volume>35</volume>: <fpage>13</fpage>–<lpage>19</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Swerdlow1">
        <label>35</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Swerdlow</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Laing</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Qiao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Slater</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Burden</surname><given-names>AC</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study</article-title>. <source>Br J Cancer</source> <volume>92</volume>: <fpage>2070</fpage>–<lpage>2075</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Chaturvedi1">
        <label>36</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chaturvedi</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Mbulaiteye</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Engels</surname><given-names>EA</given-names></name> (<year>2008</year>) <article-title>Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers</article-title>. <source>Ann Epidemiol</source> <volume>18</volume>: <fpage>230</fpage>–<lpage>234</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Jones1">
        <label>37</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jones</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Swerdlow</surname><given-names>AJ</given-names></name> (<year>1998</year>) <article-title>Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths</article-title>. <source>Am J Epidemiol</source> <volume>148</volume>: <fpage>1012</fpage>–<lpage>1017</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Key1">
        <label>38</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Key</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Appleby</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Roddam</surname><given-names>AW</given-names></name> (<year>2010</year>) <article-title>Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies</article-title>. <source>Lancet Oncol</source> <volume>11</volume>: <fpage>530</fpage>–<lpage>542</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Rinaldi1">
        <label>39</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rinaldi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cleveland</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Norat</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Biessy</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rohrmann</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies</article-title>. <source>Int J Cancer</source> <volume>126</volume>: <fpage>1702</fpage>–<lpage>1715</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Zhao1">
        <label>40</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Grossman</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Spitz</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Lerner</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk</article-title>. <source>J Urol</source> <volume>169</volume>: <fpage>714</fpage>–<lpage>717</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Dunn1">
        <label>41</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dunn</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Kari</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>French</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Leininger</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Travlos</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice</article-title>. <source>Cancer Res</source> <volume>57</volume>: <fpage>4667</fpage>–<lpage>4672</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Funfstuck1">
        <label>42</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Funfstuck</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nicolle</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Hanefeld</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Naber</surname><given-names>KG</given-names></name> (<year>2012</year>) <article-title>Urinary tract infection in patients with diabetes mellitus</article-title>. <source>Clin Nephrol</source> <volume>77</volume>: <fpage>40</fpage>–<lpage>48</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Chen1">
        <label>43</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>LT</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>SZ</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>MC</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Increased risk of urinary tract calculi among patients with diabetes mellitus–a population-based cohort study</article-title>. <source>Urology</source> <volume>79</volume>: <fpage>86</fpage>–<lpage>92</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Jankovic1">
        <label>44</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jankovic</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Radosavljevic</surname><given-names>V</given-names></name> (<year>2007</year>) <article-title>Risk factors for bladder cancer</article-title>. <source>Tumori</source> <volume>93</volume>: <fpage>4</fpage>–<lpage>12</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Chow1">
        <label>45</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chow</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Lindblad</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gridley</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Nyren</surname><given-names>O</given-names></name>, <name name-style="western"><surname>McLaughlin</surname><given-names>JK</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Risk of urinary tract cancers following kidney or ureter stones</article-title>. <source>J Natl Cancer Inst</source> <volume>89</volume>: <fpage>1453</fpage>–<lpage>1457</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Okura1">
        <label>46</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Okura</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Urban</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Mahoney</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Jacobsen</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Rodeheffer</surname><given-names>RJ</given-names></name> (<year>2004</year>) <article-title>Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure</article-title>. <source>J Clin Epidemiol</source> <volume>57</volume>: <fpage>1096</fpage>–<lpage>1103</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Margolis1">
        <label>47</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Margolis</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Lihong</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Brzyski</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bonds</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Howard</surname><given-names>BV</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Validity of diabetes self-reports in the Women’s Health Initiative: comparison with medication inventories and fasting glucose measurements</article-title>. <source>Clin Trials</source> <volume>5</volume>: <fpage>240</fpage>–<lpage>247</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Neumann1">
        <label>48</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Neumann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Weill</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ricordeau</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fagot</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Alla</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study</article-title>. <source>Diabetologia</source> <volume>55</volume>: <fpage>1953</fpage>–<lpage>1962</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0058079-Azoulay1">
        <label>49</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Azoulay</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Filion</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Assayag</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Majdan</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study</article-title>. <source>BMJ</source> <volume>344</volume>: <fpage>e3645</fpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>